VCO trials on serious COVID-19 cases, patients with comorbidities pushed cnnphilippines.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnnphilippines.com Daily Mail and Mail on Sunday newspapers.
SunStar
Editorial Cartoon by Enrico Santisas
+ December 29, 2020 EARLIER this month, President Rodrigo Duterte issued Executive Order 121, granting the Food and Drug Administration (FDA) the power to grant Emergency Use Authorization (EUA) for Covid-19 drugs and vaccines. The EUA cuts the validation process from six months to four weeks.
In its application, a vaccine company needs to present data analysis on a minimum of half of the vaccine test recipients in its third phase of clinical trials, with at least two months of safety evaluation.
In a virtual press briefing on Dec. 29, 2020, FDA Director General Enrique Domingo revealed that as of this time, the agency is yet assessing the applications of Sinovac Biotech Ltd. and Clover Pharmaceuticals, Chinese drug manufacturers both.
Imee questions sale of AstraZeneca vaccine at twice the EU price By DONA MAGSINO, GMA News
Published December 28, 2020 3:51pm Senator Imee Marcos on Monday sought an explanation from the Inter-Agency Task Force for the Management of Emerging Infectious Diseases (IATF-EID) on why the COVID-19 vaccine developed by British-Swedish firm AstraZeneca and Oxford University would be sold to the Philippine government at more than double the rate in Europe. Marcos, chair of the Senate Committee on Economic Affairs, said in a statement that the IATF is expected to ink an agreement with AstraZeneca for the procurement of 30 million doses of its vaccine at $5 or about P240 per dose once the UK health ministry authorizes its use.
SunStar
MANILA. Department of Health Secretary Francisco Duque III. (Photo from Presidential Communications)
+ December 17, 2020 HEALTH Secretary Francisco Duque III denied on Thursday, December 17, allegations that the process for the procurement of coronavirus disease (Covid-19) vaccine from Pfizer was hampered due to his failure to act on it immediately.
“I have the chronology of events, so that this is all documented. There s no such thing that I did not act quick enough,” he said in a television interview.
“When you go through a process, you cannot just be hurrying up things just like that. You have to be prudent and cautious especially because you are talking about a novel vaccine,” he added.